PSNL Personalis Inc
2,036
$1.67
$0.08
(5.03%)
| Watchers | 2,036 |
| 52-Wk Low | $0.8906 |
| 52-Wk High | $2.60 |
| Market Cap | $80.3M |
| Volume | 141,937.00 |
| 52-Wk High | $2.60 |
| 52-Wk Low | $0.8906 |
Personalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceBusiness Wire • about 1 month ago
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday...
Share to Feed
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new publication validating the companys NeXT Personal test, an ultra-sensitive, tumor-informed...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on November 15, 2023 and...
Green Alpha Advisors LLC lowered its stake in shares of Personalis, Inc. (NASDAQ:PSNL Free Report) by 6.2% in the fourth quarter, according to the company in its most recent Form 13F filing...
Personalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided...
In trading on Monday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 3.4% on the day. Components of that ETF showing particular strength include shares of Butterfly Network, up...
Pathstone Family Office LLC lifted its position in shares of Personalis, Inc. (NASDAQ:PSNL Free Report) by 149.3% during the third quarter, according to the company in its most recent filing...
Personalis, Inc. (NASDAQ:PSNL Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 826,700 shares, a decrease of...